Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - CASH & EQUIVALENTS
Cash & Equivalents ALNY - Alnylam Pharmaceuticals, Inc.
813 M
LAST VALUE
-0.45%
2 YEAR CAGR
14.11%
5 YEAR CAGR
31.35%
10 YEAR CAGR